#Peritoneal Dialysis

[drforambhuta]

The Significance of Comprehensive Health Checkups in Peritoneal Dialysis:

Regular full-body health evaluations are essential for maximizing outcomes and improving long-term survival among individuals undergoing peritoneal dialysis (PD). These assessments encompass a range of diagnostic techniques aimed at evaluating various health aspects, including kidney function, cardiovascular health, nutritional status, and metabolic indicators. Key elements of these evaluations for PD patients include:

1. Kidney Function Assessment: Routine monitoring of parameters such as serum creatinine, blood urea nitrogen (BUN), and estimated glomerular filtration rate (eGFR) aids in the early detection of declining kidney function. This information guides decisions on dialysis adequacy and modality selection.

2. Cardiovascular Screening: Thorough cardiovascular evaluations, including electrocardiography (ECG), echocardiography, and cardiac biomarker tests, provide insights into cardiac health and function. Early identification and management of cardiovascular risk factors like hypertension, dyslipidemia, and coronary artery disease are crucial for preventing cardiovascular complications and improving survival rates among PD patients.

3. Nutritional Status Assessment: Monitoring nutritional status through biochemical markers (e.g., serum albumin, prealbumin, and total protein), anthropometric measurements, and dietary assessments helps in early detection of malnutrition. This information guides interventions aimed at optimizing protein-energy status and preserving lean body mass in PD patients.

4. Metabolic Evaluation: Assessing metabolic parameters such as serum electrolytes, glucose, lipid profile, and markers of mineral and bone metabolism (e.g., calcium, phosphorus, and parathyroid hormone) assists in detecting and managing metabolic imbalances common in PD patients. Optimizing these parameters is crucial for reducing the risk of metabolic bone disease, cardiovascular calcification, and other metabolic complications associated with end-stage renal disease (ESRD).

There are several good hospitals in India that offer health checkup packages to choose from based on an individual's health status and requirements. A regular full body health checkup helps in increasing the survival rate of patients undergoing peritoneal dialysis.

[kidneyandcutiepie]

So with PD dialysis i have a tube in my belly that hooks up to a machine each evening. It pumps a sugar solution into my abdomen, lets it sit there for about two hours, then sucks it back out, along with all the toxins and fluid my kidneys would usually have filtered out. Does that four times, takes about nine hours from start to end.

The catheter is curled, with a bunch of little holes, like a soaking hose, lol. It rests behind my bladder.

So every night I clean the catheter and hook up, and the first thing that happens is the machine sucks out any fluid that‘s already there. And since there is usuusually only a teeny amount of fluid the sucking ends up grabbing my DAMN BLADDER and it feels like the weirdest cramp ever.

Having your insides vacuumed is a unique experience, indeed. I can’t even describe it in words that would give it justice. Like a terrible menstrual cramp you feel from you belly to your back to your toes! Lol, at least I know its working!

[hospotalsblog]

https://hospitalsblog.com/what-is-home-hemodialysis/

https://hospitalsblog.com/what-is-home-hemodialysis/

https://hospitalsblog.com/Hemodialysis

[mission-to-dietitian]

The difference between hemodialysis and peritoneal dialysis is essentially location. Hemo is all the body's blood, peritoneal focuses on removing fluid from the peritoneal cavity.

"Hemodialysis is ongoing dialysis (3 to 5 times a week) that cleans your blood, usually in a dialysis center. The hemodialysis access is in your arm. Peritoneal dialysis is ongoing dialysis (daily) that collects waste from the blood by washing the empty space in the abdomen (peritoneal cavity). It can be done from home."

Both require an increase in protein, 1.2-1.5g/kg.

[jesssurvives]

Just had surgery yesterday for my dialysis catheter. And i get to spend the day with my sister having a slumber party essentially. Haven’t slept in the same room in years with her.

10/10 would recommend sibling therapy.

Surgery 0/10 would not recommend. Unless you meed it to stay alive then i would give it a 9/10. Docking points for being in excruciating enough of pain to take some serious pain meds.

Also. I have an adorable kitty cat to keep me company all day.

Kitty Snuggles? 10/10 so stinking cute it’s not fun y

No.

1,000 out of 10. Would definitely recommend that as part of therapy and healing

[txhospitals123]

Peritoneal Dialysis: Definition, Types, and Benefits | TX Hospital Hyderabad

Peritoneal dialysis is a medical treatment for end-stage kidney disease. Learn about the two types of peritoneal dialysis, CAPD and APD, and their benefits over hemodialysis. TX Hospital Hyderabad offers state-of-the-art technology and top nephrologists to provide safe and effective peritoneal dialysis treatment options.

[nefronkidneycare]

Peritoneal dialysis is a type of dialysis used to treat kidney failure. It is a process of filtering toxins from the blood using the lining of the peritoneum, the thin membrane that lines the abdominal cavity, as the filter. It is a form of renal replacement therapy (RRT) that can be used in place of Hemodialysis.

[mitraindustries]

Automated Peritoneal Dialysis: The Future of Home-Based Kidney Treatment

Automated Peritoneal Dialysis (APD) is a type of PD performed using a dialysis machine. With minimal human intervention, this machine helps deliver and drain the dialysate automatically. This dialysis machine, also called a cycler, is programmed to provide the exact dialysate your clinician prescribes. An APD exchange typically takes between 8 and 12 hours and can be performed overnight while you sleep.

[alfakidneycare]

Explore the world of peritoneal dialysis with Alfa Kidney Care. Our comprehensive guide covers everything you need to know about this kidney treatment option. Learn about the process, benefits, and how it can make a positive impact on your renal health. Discover personalized care and expertise at Alfa Kidney Care for a better understanding of peritoneal dialysis.

[drforambhuta]

Understanding Dialysis:

Dialysis stands as a remarkable medical intervention, effectively mimicking the essential functions of the kidneys by removing waste products, excess fluid, and toxins from the bloodstream. This process is vital for maintaining the body's overall health and preventing the accumulation of harmful substances that can lead to severe complications. Broadly categorized into hemodialysis and peritoneal dialysis, each approach offers distinct advantages and considerations, catering to the diverse needs and preferences of patients.

Hemodialysis:

Hemodialysis represents a widely utilized form of renal replacement therapy, involving the extracorporeal circulation of blood through a specialized machine known as a hemodialyzer. This sophisticated apparatus functions as an artificial kidney, facilitating the removal of waste products and excess fluid from the blood while restoring electrolyte balance. Hemodialysis sessions typically occur several times a week at designated dialysis centers, necessitating the establishment of reliable vascular access through arteriovenous fistulas, grafts, or central venous catheters.

The procedural intricacies of hemodialysis encompass a comprehensive array of considerations, including blood flow rates, dialysate composition, and ultrafiltration targets. Despite its efficacy in achieving adequate clearance of metabolic waste, hemodialysis may pose certain challenges such as the risk of hypotension, muscle cramps, and vascular access-related complications. Furthermore, adherence to a strict dietary regimen and fluid restriction is essential to optimize treatment outcomes and minimize potential adverse effects.

Peritoneal Dialysis:

In contrast to hemodialysis, peritoneal dialysis harnesses the permeable nature of the peritoneal membrane lining the abdominal cavity to facilitate the exchange of solutes and fluids. This modality entails the instillation of a sterile dialysis solution into the peritoneal cavity via a surgically implanted catheter, allowing for the passive diffusion of waste products and excess fluid across the peritoneal membrane. Subsequently, the spent dialysate is drained from the abdomen, completing a cycle of peritoneal dialysis.

The versatility and convenience of peritoneal dialysis render it an attractive option for many patients, offering greater autonomy and flexibility in managing their treatment regimen. Home-based peritoneal dialysis affords individuals the opportunity to undergo therapy while maintaining their daily routines and minimizing disruptions to their lifestyle. Nevertheless, meticulous attention to infection control practices, including proper catheter care and aseptic technique during exchanges, is imperative to mitigate the risk of peritonitis and other infectious complications.

Doctors suggest undergoing a full body health checkup at regular intervals in case of dialysis patients to check the side effects associated with dialysis, its impact on the general health of the patient, and early management of the complications associated with the procedure.

[healthcaremarketanalysis]

Peritoneal Dialysis Market worth $12.70 Billion by 2029

The Global Peritoneal Dialysis Market, valued at US$9.12 billion in 2023, is forecasted to grow at a robust CAGR of 5.8%, reaching US$9.58 billion in 2024 and an impressive US$12.70 billion by 2029. The market is also growing due to a number of drivers. For example, the prevalence of chronic kidney disease (CKD) is increasing in various countries; the demographic population is aging; and home-based therapies are the preferred choices for patients. According to the CDC, an estimated 14% of US adults, or 35.5 million, have CKD. The CDC reported that CKD was more common among people aged 65 years or more, which accounted for 34% than people aged between 45-64 years, which had 12%, and those aged 18-44, 6%. Going by markets like China, which is one of the leading markets in terms of the global dialysis population, the government is also promoting PD as the treatment choice at home with additional reimbursement and support. All these factors-rising patient populations, government support, technological advances, and a move towards home care-converge to drive the peritoneal dialysis market significantly across the world.

Download PDF Brochure:

Browse in-depth TOC on "Peritoneal Dialysis Market"

241 - Tables

66 - Figures

252 - Pages

In this report, the peritoneal dialysis market has been segmented on the basis of offering, modality, disease indication, end user and region.

The peritoneal dialysis market is segmented into peritoneal dialysis machines, solution bags, catheters, transfer sets, other peritoneal dialysis products and services on the basis of offerings. Peritoneal dialysis solution bags accounted for the largest share of global PD market, as daily dialysis dictates the need for multiple bag consumption by every patient. In nature, as consumables, they require constant replenishment to meet demand and thus are constantly in high demand. Their very low cost and wide availability make them readily used in advanced and developing countries lacking the proper health facilities. CAPD, a "bag alone" service that uses solution bags without dependency on equipment, is another significant contributor to this market. PD machines, meanwhile, are expected to grow at the highest CAGR because of innovations that make treatment convenient enough to be done overnight with minimal intervention. In an era when patients and providers increasingly demand automated and home-based alternatives, APD machines are gaining tremendous popularity, especially in developed regions. Improved patient outcomes and increased awareness are further fuelling the demand for PD machines, putting the machinery in a great position to experience rapid market growth.

The peritoneal dialysis market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) on the basis of modality. Continuous Ambulatory Peritoneal Dialysis (CAPD) holds the largest market share of peritoneal dialysis market. CAPD is not expensive because, unlike hemodialysis, it does not require technical personnel or heavy machines, and long periods of hospitalization; thus, it is much less costly in contrast with the others when patients undergo treatment with them. Its cost-effectiveness makes CAPD an economically viable choice for both patients and health care systems. CAPD does indeed lower overhead costs that the healthcare facilities incur, especially in less developed regions with strained resources. With ready-to-use consumables like solution bags, CAPD smoothes the efficient use of healthcare resources for continuation of treatment. The cost burden on patients being much lower, health systems can use their resources much more effectively and thus reach a larger segment of the population in need. These cost benefits come coupled with the simplicity and autonomy that CAPD lends to patients, which have been mainly driving a continuous increasing trend in its adoption into a mainstay of the global peritoneal dialysis market.

The peritoneal dialysis market is segmented into end-stage renal disease, acute kidney injury and other disease on the basis of disease indication. End-stage renal disease holds the largest share in the global peritoneal dialysis market and expected to grow at the highest CAGR. Increasing incidence of diabetes and hypertension serve as some of the significant risk factors that contribute to renal failure. As the prevalence of these chronic conditions increases across different parts of the world, more people have been developing ESRD and requiring renal replacement therapies such as dialysis. Diabetes and hypertension may lead to chronic and progressive damage to the kidneys, hence the need for effective management options such as peritoneal dialysis. In comparison with in-center hemodialysis, this modality has an added advantage to the patient in that it allows home-based treatment, giving the patient more flexibility and choice.

The peritoneal dialysis market is segmented into home care settings, hospitals & independent dialysis centers and other end user on the basis of end user. Home care settings accounted for the largest share in the global peritoneal dialysis market and expected to grow at the highest CAGR. Home care for dialysis saves patients a lot of time and incurs lesser costs because frequent hospital visits can be very tiring for patients and also costly. With home dialysis, most of the costs associated with hospitals, such as transportation and facility fees, are washed away, and it becomes quite economical for patients and health care. Cost-effectiveness, is most important in managing chronic diseases like end-stage renal disease. Additionally, home care treatment schedule can be more flexible and adjusted to the individual needs, without the burden on the healthcare facilities or health care resources at large.

The peritoneal dialysis market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa and GCC Countries on the basis of geographic region. North America holds the largest share of the peritoneal dialysis market in 2023. North America, has a well-developed healthcare system that can be described as having high technology and extensive medical facilities. With these sorts of robust infrastructures, peritoneal dialysis services are thus delivered efficiently so that the patients are provided with good quality care and latest innovations in their treatment. Its hospitals and clinics are supplied with high-end apparatuses and facilities to ensure effective management and monitoring of dialysis procedures. Furthermore, the availability of well-trained care providers who specialize in nephrology increases the result outcome as they can handle various cases that are peculiar to individuals. Such an advanced healthcare scenario facilitates the adoption of peritoneal dialysis with the discovery and development of newer ideas since this continuously aids in improving the standards of treatment protocols and technologies. Over time, this creates patient-friendly therapies with improved quality of life, thus throwing North America in an even more dominant position in the global peritoneal dialysis market.

Request Sample Pages:

Prominent players in this market include Baxter International Inc. (US), Fresenius Medical Care AG (Germany), Medtronic plc (Ireland), Davita Inc. (US), Becton, Dickinson and Company (US), Utah Medical Products, Inc. (US), Terumo Corporation (Japan), Diaverum AB (Sweden), Medionics (Canada), Newsol Technologies (Canada), Apollo Dialysis Pvt Ltd (India), U.S. Renal Care, Inc. (US), Northwest Kidney Centers (US), Relavo (US), Mitra Industries Pvt Ltd (India), JMS Co., Ltd. (Japan), AMECATH (Egypt), Polymedicure (India), Huaren Pharmaceutical (China), AWAK Technologies (Singapore), Innovative Renal Care (US), Romsons (India), SSEM Mthembu Medical (Pty) Ltd (South Africa),  Renax Biomedical Technology Co., Ltd (China), and Advin Health Care (India).

BAXTER INTERNATIONAL INC. (US):

Baxter has developed a strong brand as well as from highly clinically superior products, such as IV therapies and infusion pump solutions. R&D facilities for the group exist in Belgium, Sweden, India, Italy, Germany, China, Japan, and the US. In 2023, its kidney care division registered net sales in the amount of USD 4.453 million, and its contribution to the total revenue was 30.1%. In 2022, Baxter started strategic review to improve stockholder value by offering selling and carve-out opportunities. In January 2023, the company announced some key strategic steps; one of them was to spin out Kidney Care as an independent, standalone, and publicly traded kidney care company named Vantive. Baxter also agreed to simplify the company, adjust its supply chain to operate more efficiently, and consider alternatives for its BPS business. In August 2024, Carlyle agreed with the takeover of its Kidney Care segment by Baxter; that marked the end of creating Vantive. With these alterations, Baxter is focusing toward hospital solutions and connected care and is trying to make the business model streamlined through an aligned strategy that positions toward innovation and ultimately delivers value to the stakeholders.

FRESENIUS MEDICAL CARE AG (GERMANY):

Fresenius Medical Care is one of the largest peritoneal dialysis players in the world. The company differs according to its comprehensive portfolio of dialysis products, remarkable R&D, and presence around the globe. The company operates through 42 facilities in Asia Pacific, North America, Europe, Latin America, and Africa, keeping a focus on partnership and agreement to seek further opportunity. Fresenius puts emphasis on the advanced dialysis products of renal therapies in developing the treatments for kidney disease. This further reinforces its market position. It focuses on purchases and acquisitions as well, as in the case of acquiring InterWell Health in 2022, which guides the drive towards innovation. The company operated 4,116 dialysis clinics at year-end 2022. Fifteen percent of U.S. patients are being treated in a home setting, increasing to 25% by 2025. Fresenius invests its R&D in innovative products, regenerative medicines, and the use of digital technologies such as data analytics and remote monitoring to optimize dialysis care.

MEDTRONIC PLC (IRELAND):

Medtronic Plc has some of the world's fastest-moving markets with a requirement for constant innovation in order to stay at the top. This brings about the focus of its R&D on advancing technology, improving existing products and developing less invasive solutions for emerging markets. The company participates in hundreds of clinical trials per year in order to meet the demand for clinical and economic evidence with a view to reducing costs for patients and their hospital stays. The company focuses on developing new therapies, extending the use of existing products, and co-operation with third parties to take advantage of innovation and improve the lives of patients. For instance, Medtronic in partnership with Davita launched Mozarc Medical an independent firm that would revolutionize kidney health through patient-centered technology solutions in April 2023.

For more information, Inquire Now!

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1-888-600-6441

UK +44-800-368-9399

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/